A new study suggests that weight loss and diabetes treatment may represent only a small sample of the potential uses of GLP-1 drugs. Drugs like Ozempic and Wegovy were already off to fast starts ...

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health ...

The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...

People who use weight-loss drugs can rapidly regain weight after stopping treatment, according to a new study View on ...

Those who grew up when Drug Abuse Resistance Education (D.A.R.E.) pamphlets were common in the school counselor's office are probably familiar with the “gateway drug” theory, which suggests the use of ...

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive ...

Fewer side effects, and improved chances of healing: the goal of precision medicine is to provide patients with the most individualized treatment possible. This requires a precise understanding of ...

A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article. Credit...Ricardo Tomás Supported by By Dani Blum New health research publishes every ...

Drugs like Ozempic and Wegovy were already off to fast starts because of their ability to help treat Type 2 diabetes and improve weight loss for millions of Americans. But a new study suggests that ...